Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page’s footer release version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a change to the ClinicalTrials.gov site version rather than the underlying study record.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange Detected- Revision: v3.5.0 added. - Revision: v3.4.3 removed.SummaryDifference0.1%

- Check53 days agoChange Detected- Revision updated: v3.4.2 to v3.4.3. This is a minor backend/version update and does not affect the study information or functionality.SummaryDifference0.1%

- Check81 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This is a minor version update and does not change the study details or user-facing functionality.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing the previous Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.